Obagi Medical Products, Inc. (OMPI) Misses Q1 EPS by 5c
Tweet Send to a FriendGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
Revenue Growth %: -1.0%
Financial Fact:
Net sales: 29.15M
Today's EPS Names:
CEDU, CHC, CIDM, More
Revenue Growth %: -1.0%
Financial Fact:
Net sales: 29.15M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade OMPI Now!
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q1 EPS of $0.16, $0.05 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $28.14 million.
Obagi Medical Products, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Obagi Medical Products, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Red Hat, Inc. (RHT) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
